Cynosure, Inc.

Cynosure's Second Quarter Revenue Increases 66% to Record $30.1 Million

Published in Lab Law Weekly, August 24th, 2007

Cynosure, Inc. (NASDAQ:CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, announced financial results for the quarter and six months ended June 30, 2007.

Second Quarter 2007 Financial Results

Revenues increased 66% to $30.1 million from $18.1 million for the second quarter of 2006. Gross profit margin increased 490 basis points to 63.3% of total revenues compared with 58.4% for the same period in 2006. Second quarter 2007 net income was $2.7 million, or $0.21 per diluted share, compared with net income of $1.4 million, or $0.12 per diluted share, in the second quarter of 2006.

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Law Weekly

Source: Lab Law Weekly (2007-08-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry